Insmed (INSM) Other Non-Current Liabilities (2011 - 2026)
Insmed's Other Non-Current Liabilities was $170.55 million in Q2 2026, down 5.5% from $180.5 million a year earlier and down 36.9% from the prior quarter.
Insmed (INSM) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends
At the end of FY2025, Other Non-Current Liabilities at Insmed came in at $314.34 million, up 118.0% from FY2024.
- Other Non-Current Liabilities has now increased for three consecutive years, with a five-year compound annual growth rate of 102.7% (FY2020 to FY2025).
- In earlier years, Other Non-Current Liabilities was $144.2 million in FY2024 (+70.4%), $84.6 million in FY2023 (+65.6%), $51.1 million in FY2022 (-32.5%) and $75.67 million in FY2021 (+724.4%).
- The Q2 2026 figure marks the lowest quarterly Other Non-Current Liabilities since Q1 2025.
- Compared with a year earlier, Other Non-Current Liabilities was higher in seven of the last eight quarters, with growth averaging 83.9%.
- The best year-over-year quarter for Other Non-Current Liabilities over five years was Q4 2021 (growth of 724.4%); the worst was Q1 2023 (a decline of 41.6%).
- Per Business Quant data, INSM's Other Non-Current Liabilities in the three quarters before Q2 2026 was $270.31 million (Q1 2026), $314.34 million (Q4 2025) and $259.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Insmed | 24.91 Bn | 19.42 Bn | 358.27 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 170.55 Mn |
| Mar 31, 2026 | 270.31 Mn |
| Dec 31, 2025 | 314.34 Mn |
| Sep 30, 2025 | 259.60 Mn |
| Jun 30, 2025 | 180.50 Mn |
| Mar 31, 2025 | 159.90 Mn |
| Dec 31, 2024 | 144.20 Mn |
| Sep 30, 2024 | 157.60 Mn |
| Jun 30, 2024 | 101.50 Mn |
| Mar 31, 2024 | 63.70 Mn |
| Dec 31, 2023 | 84.60 Mn |
| Sep 30, 2023 | 69.90 Mn |
| Jun 30, 2023 | 46.40 Mn |
| Mar 31, 2023 | 38.60 Mn |
| Dec 31, 2022 | 51.10 Mn |
| Sep 30, 2022 | 51.80 Mn |
| Jun 30, 2022 | 55.60 Mn |
| Mar 31, 2022 | 66.12 Mn |
| Dec 31, 2021 | 75.67 Mn |
| Sep 30, 2021 | 76.49 Mn |
Insmed Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=INSM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();